Profusa, Inc. (PFSA): Entry into a Material Definitive Agreement
Profusa, Inc. (PFSA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, the Company is party to a Securities Purchase Agreement, dated as of February 11, 2025 (as amended, the “Purchase Agreement”), by and among the Company, Ascent Partners Fund LLC, a Delaware limited lia
- Instrument
- Senior Secured Convertible Promissory Note
- Gross proceeds
- $700,000.00
- Coupon
- 7% per annum
- Maturity
- October 15, 2027
Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.
How this was made
The 30-second read
Why it matters
The note adds $769k of senior secured debt and convertible equity potential, which may dilute existing shareholders and increase leverage.
Market read
A primary disclosure of a financing instrument that could affect PFSA's share price through dilution and debt considerations.
What to watch
Potential for the note to be prepaid after a subsequent equity offering, reducing dilution risk.
Background
Profusa Inc. (NASDAQ: PFSA) is a micro‑cap biotech developing diagnostic technologies. The filing details a financing transaction with Ascent Partners Fund.
Ticker impact
Profusa filed an 8‑K reporting issuance of a $769,230 senior secured convertible note with a $4.28 conversion price.
downward pressure as investors price in dilution risk and higher leverage
New debt and conversion rights increase share supply; interest rate and default provisions add risk.
Market effects
Limited to biotech financing trends; may signal increased use of convertible notes for capital raises.
Primarily affects US micro‑cap biotech investors.
Low; no broader market impact.
Counterpoint
If the note converts at a floor price above current levels, it could provide upside for shareholders.
Key entities
- companyProfusa, Inc.
Issuer of the convertible note.
- investorAscent Partners Fund LLC
Purchaser and collateral agent for the note.